# Safety and Efficacy of the Symetis ACURATE Neo/TF Compared to the Edwards SAPIEN 3 Bioprosthesis.

Study · id `cardio:ct-nct03011346` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03011346](<https://clinicaltrials.gov/study/NCT03011346>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03011346

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 739 participants.

## Technical summary

Registry record NCT03011346. Randomized; no masking; primary purpose treatment. Start 2017-02-08 (actual); primary completion 2019-05-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 739 participants (enrolled count; ClinicalTrials.gov record NCT03011346, source copy `cardio:ctgov-nct03011346-2022-03-10`, retrieved 2026-10-26)
- Started: 2017-02-08 (actual) (ClinicalTrials.gov record NCT03011346, source copy `cardio:ctgov-nct03011346-2022-03-10`, retrieved 2026-10-26)
- Primary completion: 2019-05-02 (actual) (ClinicalTrials.gov record NCT03011346, source copy `cardio:ctgov-nct03011346-2022-03-10`, retrieved 2026-10-26)
- Completion: 2022-02-16 (actual) (ClinicalTrials.gov record NCT03011346, source copy `cardio:ctgov-nct03011346-2022-03-10`, retrieved 2026-10-26)
- Countries: Germany; Netherlands; Switzerland; United Kingdom (ClinicalTrials.gov record NCT03011346, source copy `cardio:ctgov-nct03011346-2022-03-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03011346-2022-03-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of the Symetis ACURATE Neo/TF Compared to the Edwards SAPIEN 3 Bioprosthesis.
- Acronym: SCOPE I
- Condition: Aortic Valve Stenosis
- Intervention (Device): Symetis ACURATE neo/TF transfemoral TAVI system
- Intervention (Device): Edwards Sapien 3 Transcatheter Heart Valve
- Lead sponsor: Insel Gruppe AG, University Hospital Bern
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Insel Gruppe AG, University Hospital Bern (`cardio:org-insel-gruppe-ag-university-hospital-bern`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial (`cardio:pubmed-31570258`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Final 3-Year Outcomes of a Randomized Trial Comparing a Self-Expanding to a Balloon-Expandable Transcatheter Aortic Valve (`cardio:pubmed-37417229`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Obstructive Coronary Artery Disease and Health Status in Transcatheter Aortic Valve Replacement: A Post Hoc Analysis of the SCOPE I Randomized Clinical Trial (`cardio:pubmed-41364435`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Relationship between baseline patient-reported health status and patient-centered outcomes after transcatheter aortic valve replacement (`cardio:pubmed-42203165`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: d4b48d3c081d557f2b68f4ca0ad7d95deb9f809e2c7f4917e5b0a1132157423b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
